These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12106798)

  • 1. Pharmacology of neuropeptide Y receptor antagonists. Focus on cardiovascular functions.
    Malmström RE
    Eur J Pharmacol; 2002 Jun; 447(1):11-30. PubMed ID: 12106798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y Y1 receptors in vascular pharmacology.
    Franco-Cereceda A; Liska J
    Eur J Pharmacol; 1998 May; 349(1):1-14. PubMed ID: 9669490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists.
    Edvinsson L; Erlinge D; Sun XY; Hedner T
    Pharmacol Toxicol; 1994; 74(4-5):193-201. PubMed ID: 8090686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
    Malmstrom RE; Lundberg JM
    Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic co-transmission: the coordinated action of ATP and noradrenaline and their modulation by neuropeptide Y in human vascular neuroeffector junctions.
    Pablo Huidobro-Toro J; Verónica Donoso M
    Eur J Pharmacol; 2004 Oct; 500(1-3):27-35. PubMed ID: 15464018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
    Pons J; Lee EW; Li L; Kitlinska J
    Curr Opin Investig Drugs; 2004 Sep; 5(9):957-62. PubMed ID: 15503651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and regulation of the cardiovascular system.
    Shine J; Potter EK; Biden T; Selbie LA; Herzog H
    J Hypertens Suppl; 1994 Dec; 12(10):S41-5. PubMed ID: 7769490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation.
    Racchi H; Schliem AJ; Donoso MV; Rahmer A; Zúñiga A; Guzmán S; Rudolf K; Huidobro-Toro JP
    Eur J Pharmacol; 1997 Jun; 329(1):79-83. PubMed ID: 9218687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments with neuropeptide Y receptor antagonists.
    Lundberg JM; Modin A; Malmström RE
    Trends Pharmacol Sci; 1996 Sep; 17(9):301-4. PubMed ID: 8885691
    [No Abstract]   [Full Text] [Related]  

  • 12. SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.
    Malmström RE; Modin A; Lundberg JM
    Eur J Pharmacol; 1996 Jun; 305(1-3):145-54. PubMed ID: 8813545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.
    Malmström RE; Lundberg JO; Weitzberg E
    Eur J Pharmacol; 2002 Mar; 439(1-3):113-9. PubMed ID: 11937100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo.
    Malmström RE; Balmér KC; Weilitz J; Nordlander M; Sjölander M
    Eur J Pharmacol; 2001 Apr; 418(1-2):95-104. PubMed ID: 11334870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications.
    Benarroch EE
    Ann Neurol; 1994 Jul; 36(1):6-13. PubMed ID: 8024263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF; Sawin LL
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and a nerve-derived vascular growth factor.
    Zukowska-Grojec Z
    Adv Pharmacol; 1998; 42():125-8. PubMed ID: 9327862
    [No Abstract]   [Full Text] [Related]  

  • 20. 5. Neuropeptide Y receptor antagonists in cardiovascular pharmacology.
    Malmström RE
    Prog Med Chem; 2004; 42():207-44. PubMed ID: 15003722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.